Related Experiment Videos
Genetics of inflammatory bowel disease
J Satsangi1, M Parkes, D P Jewell
1Nuffield Department of Medicine, John Radcliffe Hospital, Headington, Oxford, U.K.
Clinical Science (London, England : 1979)
|July 31, 1998
Summary
Genetic factors significantly influence inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. Genome-wide studies identified specific chromosomal regions linked to IBD, suggesting polygenic inheritance and potential for targeted therapies.
Area of Science:
- Genetics
- Gastroenterology
- Immunology
Background:
- The etiology of chronic inflammatory bowel diseases (IBD), Crohn's disease (CD), and ulcerative colitis (UC) remains uncertain, with limited insights from environmental factors and immune dysfunction.
- Twin and sibling studies strongly indicate a significant genetic contribution to IBD pathogenesis.
Purpose of the Study:
- To investigate the genetic underpinnings of IBD, including CD and UC.
- To identify specific genetic loci and their association with disease susceptibility and clinical characteristics.
Main Methods:
- Analysis of concordance rates in twins and siblings, relative risk calculations in families.
- Comparison of clinical patterns in multiply affected families, including parent-child pairs.
- Linkage analysis and allelic association studies, including genome-wide searches for susceptibility loci.
Main Results:
- Siblings of Crohn's disease patients exhibit significantly elevated relative risks for CD, UC, and overall IBD.
- High concordance for disease characteristics was observed within families, with evidence of genetic anticipation in parent-child pairs.
- The major histocompatibility complex is implicated in UC but not CD. Genome-wide analysis identified susceptibility loci on chromosomes 3, 7, 12 for IBD, with specific loci linked to UC (chromosomes 2, 6) and CD (chromosome 16).
Conclusions:
- IBD, including CD and UC, are complex polygenic disorders with significant genetic determinants.
- Identification of specific susceptibility loci provides a foundation for further gene discovery and potential therapeutic strategies.
- Further fine mapping of identified loci is crucial for gene identification and realizing clinical benefits.